Peripheral Neuropathy Trial, Recruiting NCT06638424 Sponsor: University Hospital, Strasbourg, France Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06638424
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who had cataract surgery at HUS (the hospital where this trial is based) between January 2022 and January 2024
  • People who did not previously object to their medical data being used for scientific research
  • People who had the relevant eye measurements taken at their pre- and post-surgery appointments

Who may not be able to join:

  • People whose medical file contains a recorded objection to their data being used for scientific research
  • People who used preserved (stored) eye drops for an extended period of time
  • People with a known long-term condition affecting the surface of the eye, such as shingles, herpes, Sjögren's syndrome, or graft-versus-host disease
  • People who are under 18, or who are under legal guardianship or a court-appointed protection arrangement

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33 3 69 55 11 16

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 April 2024
Est. completion
1 April 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

To assess whether cataract surgery induces an increased risk of corneal epithelial alterations in diabetic patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov